Target intelligence / Profile preview

Microtubule network protein beta-tubulin subunit (Beta-tubulin)

Target
Beta-tubulin
Molecular classification
Cytoskeletal protein, Microtubule subunit, Structural protein
01

Overview

Beta-tubulin is one half of the alpha/beta tubulin heterodimer that forms the basic building block of microtubules, which are cylindrical polymers critical for maintaining eukaryotic cell structure, intracellular transport, chromosome segregation during mitosis/meiosis, ciliary/flagellar motility, and other essential cellular processes. Each monomer binds GTP; GTP bound at the E-site on β-subunit can be hydrolyzed after incorporation into the growing microtube filament—a process central to dynamic instability required for normal function. Multiple gene products/isotypes exist with tissue-specific expression patterns; these differences can influence drug sensitivity/resistance profiles. The intermediate domain contains binding sites for important anticancer drugs such as paclitaxel/taxol. Because disruption or stabilization of this system impairs cell division—especially in rapidly proliferating tumor cells—beta-tublin has become a major focus for chemotherapeutic intervention but also presents challenges related to toxicity due its fundamental role across many healthy tissues.

Other names
Beta-tubulinβ-tubulinTubB (in some bacterial contexts)TUBB (gene symbol for human beta-tubulins)Microtubule protein beta chain
02

Mechanism of action

Drugs targeting beta-tubulin generally act by: - Stabilizing microtubules, preventing their depolymerization (e.g., taxanes like paclitaxel), which blocks mitosis and leads to apoptosis in rapidly dividing cells. - Destabilizing microtubules, inhibiting their polymerization or promoting disassembly (e.g., vinca alkaloids like vincristine), also leading to mitotic arrest and cell death.

03

Biological functions

Cell division (mitosis and meiosis)Intracellular transportMaintenance of cell shape and structureChromosome segregation during mitosisCilia and flagella movement
04

Disease associations

Cancer (targeted by many chemotherapeutic agents)Neurodegenerative diseases (due to roles in axonal transport)Other diseases involving cytoskeletal dysfunction
05

Safety considerations

Neurotoxicity/peripheral neuropathy due to effects on neuronal microtubles.Myelosuppression from effects on dividing hematopoietic cells.
06

Interacting drugs

Paclitaxel (Taxol)

5 more in the full profile.

07

Biomarkers

Predicting response/resistance to anti-microtubule drugs in cancer therapy.Monitoring efficacy/toxicity of chemotherapy regimens.

Beyond the preview

Go deeper on Microtubule network protein beta-tubulin subunit (Beta-tubulin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule network protein beta-tubulin subunit (Beta-tubulin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call